Luminex develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The Company’s open-architecture xMAP® Technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. Systems using xMAP Technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time. 

Company Growth (employees)
Austin, US
Size (employees)
914 (est)
Luminex is headquartered in Austin, US

Luminex Office Locations

Luminex has offices in Austin, Madison, 's-Hertogenbosch, Toronto and in 2 other locations
Austin, US (HQ)
12212 Technology Blvd
Shanghai, CN
Room 353 No.3058 Pusan Road
Minato-ku, JP
Kamiyacho Sankei Bldg 3F 1-7-2 Azabudai
Toronto, CA
900 439 University Ave
's-Hertogenbosch, NL
1 Het Zuiderkruis
Madison, US
1224 Deming Way

Luminex Financials and Metrics

Luminex Financials

Luminex's revenue was reported to be $270.6 m in FY, 2016

Revenue (Q2, 2017)

76.5 m

Gross profit (Q2, 2017)

50.1 m

Gross profit margin (Q2, 2017), %


Net income (Q2, 2017)

5.5 m

EBIT (Q2, 2017)

7.5 m

Market capitalization (13-Nov-2017)

907.1 m

Cash (30-Jun-2017)

103.7 m
Luminex's current market capitalization is $907.1 m.
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


10.7 m227 m237.7 m270.6 m

Revenue growth, %


Cost of goods sold

69.8 m67.1 m69 m91 m

Gross profit

(59.1 m)159.9 m168.7 m179.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


50.8 m56.6 m55.6 m56.7 m57.7 m58.9 b60.6 b63 m64.2 m71.2 m77.8 m76.5 m

Cost of goods sold

20 m16.6 m17.5 m17.7 m17.5 m15.6 b18.8 b18.2 m19.2 m25.6 m25 m26.4 m

Gross profit

30.8 m40 m38.1 m39 m40.2 m43.3 b41.8 b44.8 m44.9 m45.7 m52.8 m50.1 m

Gross profit Margin, %

USDY, 2009Y, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016


90.8 m89.5 m58.3 m42.8 m67.9 m91.7 m128.5 m93.5 m

Accounts Receivable

30.9 m29.1 m28.9 m32.4 m


40.8 m

Current Assets

146.4 m177 m209.5 m173.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


57.2 m77.4 m86.7 m89.1 m94.9 m111.1 m119.6 m134.3 m81.7 m84.1 m86.5 m103.7 m

Accounts Receivable

30.2 m27 m27.6 m27.4 m25.1 m22.2 m26.2 m29.4 m27 m30 m37 m33.1 m


29.7 m30.9 m31.2 m33.1 m33.7 m32.6 m29.3 m31.2 m41.5 m41.5 m43.7 m47.1 m

Current Assets

130 m150.3 m157.5 m163.1 m172.2 m192.7 m201.9 m217.7 m159.2 m164.9 m173.5 m192.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7.1 m39 m36.9 m13.8 m

Depreciation and Amortization

15.9 m14.2 m

Accounts Receivable

2.3 m2 m

Accounts Payable

962 k841 k
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

796 k6 m4.7 m5.6 m7.5 m2.6 b6.4 b8.8 m5.7 m2.8 m9.2 m

Accounts Receivable

27.6 m27.4 m25.1 m22.2 m26.2 m29.4 m27 m30 m37 m

Accounts Payable

8.9 m10.1 m11 m8 m9.3 m6.9 m11.3 m9.9 m9.1 m

Income Taxes Paid

(1.6 m)(2.2 m)(45 k)(2.9 m)
Y, 2017

Financial Leverage

1.1 x
Show all financial metrics

Luminex Operating Metrics

FY, 2015FY, 2016

Patents Pending


Patents Issued

Show all operating metrics

Luminex Market Value History

Luminex Median Salaries

Source: 16 public H-1B filings from Luminex

Luminex's Web-traffic and Trends

Luminex Online and Social Media Presence

Luminex News and Updates

Global SNP Genotyping Highlights Market Size, Opportunities, Trends and Forecast 2022

The report provides in depth study of “SNP Genotyping” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization Posted via Industry Today. Follow us on Twitter @IndustryToday

Luminex Company Life and Culture

You may also be interested in